The myth: "Antipsychotics turn people into zombies. They flatten emotion, kill creativity, and leave the person staring blankly into space." This stereotype is one of the main reasons people stop taking medication, often with serious consequences.
Modern antipsychotics, dosed carefully, allow most people to function and feel like themselves; the "zombie" image largely reflects high-dose typical antipsychotics from earlier eras and remains rare in current practice.
Where the image comes from
The "zombie" stereotype has real historical roots. The first antipsychotics — chlorpromazine, haloperidol, and other "typical" or "first-generation" agents — were often used in very high doses in mid-20th-century state hospitals. At those doses, side effects such as sedation, parkinsonism (slowed movement, blank facial expression, shuffling gait), and emotional blunting were common.
Films set in psychiatric hospitals captured this image: the silent patient in pyjamas, eyes glassy. That picture was sometimes accurate for the time. It is much less accurate today.
What changed
Several developments have made the zombie image largely outdated:
- Lower doses. Modern prescribing emphasises the lowest effective dose. The doses used historically — sometimes 1,000 mg/day chlorpromazine equivalents — are very rarely seen now.
- Atypical antipsychotics. Second-generation medications such as risperidone, aripiprazole, lurasidone, brexpiprazole, and lumateperone are generally less likely than older agents to cause severe parkinsonism and emotional blunting at therapeutic doses, though they have their own side effects (notably metabolic).
- Better monitoring. Side effects such as akathisia and parkinsonism are recognised earlier and addressed with dose adjustment, switching, or adjuncts (e.g., propranolol for akathisia, benztropine for parkinsonism).
- Shared decision-making. Patients now have more voice in choosing among options based on side-effect tolerability.
What the evidence shows about quality of life
Major guidelines including the UK's NICE CG178 and the APA practice guideline for schizophrenia emphasise individualised antipsychotic choice with attention to side-effect profile and patient preference. Reviews of long-term outcomes consistently show that maintained antipsychotic treatment is associated with lower mortality, lower relapse risk, and better functional outcomes than discontinuation.
People on appropriately dosed antipsychotics work, study, marry, raise children, write books, run companies. The image of a uniformly flattened patient is not what most people experience.
That said, side effects are real
Modern antipsychotics are not side-effect free. Common ones include:
- Sedation — particularly with olanzapine, quetiapine, and clozapine
- Weight gain and metabolic changes — particularly with olanzapine and clozapine
- Akathisia — restlessness, common with aripiprazole and high-potency typicals
- Parkinsonism — slowed movement, mask-like face, particularly with higher doses or first-generation drugs
- Sexual side effects — common across the class
- Tardive dyskinesia — involuntary movements, more common with long-term typical use but still possible with atypicals
Sometimes patients on overly high doses or sedating combinations do describe feeling flat or distant. That is real, and it is usually addressable by talking to the prescriber. It is not an inevitable feature of treatment.
What helps if you feel "flattened"
- Tell your prescriber specifically what is bothering you (energy, motivation, libido, emotion)
- Ask whether dose can be lowered while preserving symptom control
- Ask whether a different medication might fit better
- Check for sedating co-prescriptions that could be reduced
- Address sleep, depression, and substance use, which can all mimic flatness
- Distinguish negative symptoms (which can feel similar but are not caused by medication) from medication effects
The hidden cost of the myth
The biggest harm of the "zombie" myth is that it convinces people to stop their medication. Stopping antipsychotics — particularly suddenly — is associated with high relapse risk and, over time, worse cognitive and functional outcomes. The stories of people who walked away from medication often share a turning point: someone repeated the zombie myth, the patient internalised it, and stopped.
If you are considering stopping or changing medication, do it in conversation with the person who prescribed it. Sudden discontinuation is more likely to cause problems than a careful, planned adjustment.
The bottom line
The zombie stereotype belongs to an earlier era of psychiatry. Modern antipsychotic care aims for the lowest effective dose, individual fit, and proactive side-effect management. Side effects exist and matter — but the assumption that medication necessarily flattens or empties a person is outdated, and acting on it can cost people their stability.
This article is for educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a qualified mental health professional. If you or someone you know is in crisis, call or text 988 in the US, or your local emergency number.